http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2802174-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872dd7cd609eb2a937dcfd303d521798 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2015-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f679a97ac7041a853e26c52a67db9e1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7220e6ff5ee0b49f364b677b3b9b63a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3787cab67973dbe6617771381d6e2080 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e714598d9b5f5b1119156221821b00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2ed8cad65ebb7bd4ca284c5a032c70e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8363c3423c64fc6b1067a65db452e73e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eae2f7b77e7bd0bddc10c0413f2e71c |
| publicationDate | 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2802174-T3 |
| titleOfInvention | Compounds |
| abstract | A compound of Formula (I) or a pharmaceutically acceptable salt thereof ** (See formula) ** where R1 is selected from the group consisting of H, C1-3 alkoxy, C1-3 alkyl, and halo; R2 is C1-5 alkyl optionally substituted with one or more substituents independently selected from the group consisting of OH, C1-3 alkoxy, halo, and CN; or R2 is - (CRaRb) nY, where n is 0, 1 or 2, each occurrence of Ra and Rb is independently H or methyl, Y is 1) a four to six membered heterocyclyl optionally substituted with one or more substituents that are independently selected from the group consisting of C1-3 alkyl, halo, OH, oxetanyl, C1-3 haloalkyl, and morpholinyl; 2) a C3-6 cycloalkyl optionally substituted with one or more substituents independently selected from the group consisting of C1-3 alkyl, halo, OH, or oxetanyl, C1-3 haloalkyl, and morpholinyl, or 3) ** (See formula) ** each of which is optionally substituted with an OH group; R3 is selected from the group consisting of H, C1-3 alkoxy, C1-3 alkyl, C3-6 cycloalkyl, and halo; R4 is CH or N; R5 is H, CN, or methyl; and R6 is selected from the group consisting of C1-3 alkoxy, and -O-CH2-C3-6 cycloalkyl. |
| priorityDate | 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 746.